SCHEMBL7984932

SCHEMBL7984932

CC(C)(C)c1ccc(Cn2cnc3nc(-c4ccncc4)nc(O)c32)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCC8 Q09428 1/20 0.43
KCNJ11 Q14654 1/20 0.43
NR1H4 Q96RI1 6/20 0.41
KIF11 P52732 1/20 0.38
NPC1 O15118 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
TSHR P16473 1/20 0.38
HTT P42858 1/20 0.38
RAB9A P51151 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
HSP90AA1 P07900 2/20 0.35
HSP90AB1 P08238 2/20 0.35
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35
NCSTN Q92542 1/20 0.35
APH1A Q96BI3 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974490 0.90 NR1H4 (0.47) ABCC8KCNJ11NR1H4TP53HPGD
SCHEMBL7988522 0.89 NR1H4 (0.44) ABCC8KCNJ11NR1H4NPC1LMNA
SCHEMBL7987361 0.88 MET (0.45) ABCC8KCNJ11NR1H4NPC1MAPT
SCHEMBL7985826 0.87 NPC1 (0.41) NPC1LMNAHPGDHTTRAB9A
SCHEMBL7974237 0.87 KIF11 (0.42) ABCC8KCNJ11NR1H4KIF11NPC1
SCHEMBL7984868 0.86 NR1H4 (0.42) ABCC8KCNJ11NR1H4NPC1MAPT
SCHEMBL7985275 0.85 MET (0.46) HDAC8HDAC6CNOT7METCYP19A1
SCHEMBL7974441 0.85 GRK2 (0.43) HPGDTSHRCNOT7ADORA3
SCHEMBL7974277 0.84 NR1H4 (0.44) ABCC8KCNJ11NR1H4HSP90AA1HSP90AB1
SCHEMBL7991400 0.83 NR1H4 (0.43) ABCC8KCNJ11NR1H4LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed